Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NovaBay
NovaBay
NovaBay: Upcoming Auriclosene Data Could Be A Catalyst
Seeking Alpha
Tue, 06/11/13 - 05:02 pm
auriclosene
NovaBay
The Market Waits For NovaBay
Seeking Alpha
Thu, 01/24/13 - 10:28 am
NovaBay
For NovaBay, Simplicity Is The Father Of Invention
Seeking Alpha
Mon, 11/12/12 - 11:29 am
NovaBay
Allergan
new molecular entity
NME
Forest Labs
Merck
Pfizer
Theravance
NovaBay: Potential Of NVC-422 For Treating Impetigo Is Key Factor In Recent Long Recommendation
Seeking Alpha
Mon, 11/5/12 - 11:32 am
NovaBay
NVC-422
impetigo
Galderma and NovaBay Enroll First Patients in Phase 2b Clinical Study of NVC-422 for Impetigo
Yahoo
Mon, 09/24/12 - 10:23 am
Galderma
NovaBay
NVC-422
impetigo
NovaBay Pharmaceuticals:Why It's A Good Idea To Act Now
Seeking Alpha
Fri, 08/17/12 - 11:38 am
NovaBay
NovaBay Pharmaceuticals: A Potential Bargain With Catalysts Pending
Seeking Alpha
Wed, 06/13/12 - 12:37 pm
NovaBay
Aganocide
NovaBay Ocular Trial Taps Broad Activity Of Its Anti-Infective
Seeking Alpha
Wed, 05/30/12 - 10:28 am
NovaBay
NVC-422
adenoviral conjunctivitis
NovaBay's Market Cap Doesn't Adequately Value Pipeline Potential
Seeking Alpha
Wed, 05/23/12 - 11:59 am
NovaBay